
Accelerated approvals, surrogate end points, and high drug costs are reshaping cancer center formulary decisions, explained panelists at PCOC.
Supplements and Featured Publications
about 26 years ago
Participating Facultyabout 26 years ago
Introductionabout 26 years ago
Current Concepts in Erectile Dysfunctionabout 26 years ago
Partner and Relationship Issues in the Treatment of Erectile Dysfunctionabout 26 years ago
A Clinical Perspective on Erectile Dysfunction Therapiesabout 26 years ago
CME Quizabout 26 years ago
Bibliography





